Inhibition of the primary immune response in man by anti-metabolites.
D000906:Antibodies; D000941:Antigens; D000963:Antimetabolites / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007938:Leukemia / Q000188:drug therapy; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy; D011241:Prednisone / Q000494:pharmacology; D014605:Uveitis / Q000188:drug therapy; D014750:Vincristine / Q000494:pharmacology
D000906:Antibodies; D000941:Antigens; D000963:Antimetabolites; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate